Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Cash from Financing Activities (2022 - 2026)

Axsome Therapeutics' Cash from Financing Activities history spans 5 years, with the latest figure at $3.0 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 89.77% to $3.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $75.2 million, a 14.85% decrease, with the full-year FY2025 number at $101.5 million, up 75.42% from a year prior.
  • Cash from Financing Activities hit $3.0 million in Q1 2026 for Axsome Therapeutics, down from $16.4 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for AXSM hit a ceiling of $246.1 million in Q2 2023 and a floor of -$1.2 million in Q1 2024.
  • Historically, Cash from Financing Activities has averaged $45.8 million across 5 years, with a median of $29.3 million in 2025.
  • The widest YoY moves for Cash from Financing Activities: up 712300.0% in 2024, down 102.3% in 2024.
  • Tracing AXSM's Cash from Financing Activities over 5 years: stood at $1.1 million in 2022, then crashed by 100.19% to -$2000.0 in 2023, then soared by 712300.0% to $14.2 million in 2024, then rose by 15.03% to $16.4 million in 2025, then tumbled by 81.73% to $3.0 million in 2026.
  • Business Quant data shows Cash from Financing Activities for AXSM at $3.0 million in Q1 2026, $16.4 million in Q4 2025, and $21.3 million in Q3 2025.